Sign In
Buy XBI
$129.83
+2.07 (+1.62%)
At Close: Jun 03, 2026
‘Buying stuff like it's going out of fashion': Biotech M&A on track for best year since pre-Covid
01:45am, Thursday, 04'th Jun 2026
So far in 2026, biotech deals amounted to $106 billion over 201 transactions, according to PitchBook data. That momentum in dealmaking comes despite an interest rate environment that has turned for th
VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost
08:07am, Thursday, 28'th May 2026
Expense ratios, yield, and sector breadth set these healthcare ETFs apart-see how their risk profiles and portfolio strategies compare.
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
07:20am, Wednesday, 27'th May 2026
Making its debut on 01/31/2006, smart beta exchange traded fund State Street SPDR S&P Biotech ETF (XBI) provides investors broad exposure to the Health Care ETFs category of the market.
Biotech Investors Are Tuning Out the MAHA Chaos
05:30am, Wednesday, 20'th May 2026
The Food and Drug Administration is still in turmoil, but Wall Street no longer cares.
If You Hold This Healthcare ETF, You're Losing Big
11:12am, Tuesday, 19'th May 2026
The Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC) is down about 5% year to date while the S&P 500 is up 7%.
SPDR S&P Biotech ETF (XBI) Price Forecast: Long-Term Breakout Fuels Biotech Strength
05:07pm, Friday, 08'th May 2026
XBI continues to strengthen following a multi-month breakout, with bullish trend signals supporting upside targets near key Fibonacci retracement resistance levels.
Locking In A Quick Gain In This Biotech ETF Made Room For Better Swing Trades; Here's Why
03:08pm, Friday, 01'st May 2026
Locking in profits while you have them can help avoid downturns.
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
07:21am, Thursday, 30'th Apr 2026
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund lau
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
07:20am, Tuesday, 28'th Apr 2026
The iShares Biotechnology ETF (IBB) was launched on 02/05/2001, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
Deltec Asset Management LLC Invests $1.22 Million in SPDR S&P Biotech ETF $XBI
05:05am, Monday, 27'th Apr 2026
Deltec Asset Management LLC acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Com
Cwm LLC Buys 10,699 Shares of SPDR S&P Biotech ETF $XBI
03:47am, Friday, 24'th Apr 2026
Cwm LLC grew its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 77.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Comm
Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position Now
01:22pm, Thursday, 23'rd Apr 2026
Biotech has reasserted itself over the past year as drug approvals,
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)?
07:21am, Wednesday, 22'nd Apr 2026
Launched on January 31, 2006, the State Street SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the eq
Greystone Financial Group LLC Buys Shares of 5,395 SPDR S&P Biotech ETF $XBI
04:46am, Tuesday, 21'st Apr 2026
Greystone Financial Group LLC purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the undefined quarter, according to the company in its most recent 13F filing with the SEC. T
Altfest L J & Co. Inc. Acquires 17,250 Shares of SPDR S&P Biotech ETF $XBI
03:14am, Sunday, 12'th Apr 2026
Altfest L J and Co. Inc. boosted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 13.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchang
